Thanks
@Shellbell , great posts
The issue is the SP is just sooooooo Depressed , the price of 0.006c negates investment by many who avoid the penny dreadfuls , the damage going forward for sentiment are the charts. For those having a quick glance the SP looks like a reflection of poor science and the BOD have shown absolutely no care or regard for ensuring SH Value, Everyone is underwater on this stock...
Those that have followed the progress and understand the course of events that created the current crash in value are Holders,,, it is almost impossible to attract investors once such a large erosion of SH value has occurred especially of this magnitude.
Agree with your above posts the Science here does hold significant value but the amount of PR and market Messaging even on the most positive results will need to be applied to change market sentiment.
I've been in Biotech for just over 25 years and I can attest that Management just sat Idle with the SP decline from 3.2c to the Suspension sp of 1.4c then releasing Positive Data that was BlockBuster " Complete Response" you don't get a better result in Oncology... so for then Hopper and Co to buy in at .008 with a free option just smashed the SP and increased the SOI to manic proportions,,, yes it was significant that Hopper put up $1m but we know that would have been hurt money required by the other SOPH investors as a sign of commitment.
Rebecca is doing everything in her power to keep pushing the Science forward , she responds to all correspondence and burns the midnight oil as I have replies at 10;30pm from her. I can only imaging the SP had the previous CEO put in 1/10 of what Rebecca is applying.
IMHO the market aee a huge rinse coming , most don't trust the BOD or Hopper , I've never met the bloke so dont like to form opinions of people I have not met.. I own a truckload of CHM at a significantly higher price than todays pittance so I'm not downramping but unless significant REAL EFFORT is applied to mop up the claret that this stock has delivered to current investors then regrettably I cant see CHM being able to attract new investors and liquidity will slowly disappear as it has been with lower and lower volumes..
Like you I believe the Science is sound and valuable , I believe Rebecca is valuable with the Science Team but actual Management here at CHM should be absolutely ashamed of the current position that they resided over and managed the Company into.. NZT
